These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17650100)

  • 1. Modeling the effects of treating diabetic wounds with engineered skin substitutes.
    Waugh HV; Sherratt JA
    Wound Repair Regen; 2007; 15(4):556-65. PubMed ID: 17650100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage dynamics in diabetic wound dealing.
    Waugh HV; Sherratt JA
    Bull Math Biol; 2006 Jan; 68(1):197-207. PubMed ID: 16794927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special segment: soft tissue matrices--Apligraf bilayered skin substitute to augment healing of chronic wounds in diabetic patients.
    DeCarbo WT
    Foot Ankle Spec; 2009 Dec; 2(6):299-302. PubMed ID: 20400430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wound healing in venous ulcers; mechanisms, approach and modern developments].
    Gibbs S; van den Hoogenband HM; de Boer EM
    Ned Tijdschr Geneeskd; 2007 Mar; 151(11):635-40. PubMed ID: 17441566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
    Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
    Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special segment: soft tissue matrices--Bilayered bioengineered skin substitute to augment wound healing.
    DeCarbo WT
    Foot Ankle Spec; 2009 Dec; 2(6):303-5. PubMed ID: 20400431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1.
    Mi Q; Rivière B; Clermont G; Steed DL; Vodovotz Y
    Wound Repair Regen; 2007; 15(5):671-82. PubMed ID: 17971013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of advanced biological and tissue-engineered wound products.
    Collier M
    Nurs Stand; 2006 Oct 25-31; 21(7):68, 70, 72 passim. PubMed ID: 17087417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of tissue-engineered mucosal substitutes in the dog palate.
    Ophof R; Maltha JC; Kuijpers-Jagtman AM; Von den Hoff JW
    Eur J Orthod; 2008 Feb; 30(1):1-9. PubMed ID: 17971350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired wound healing in an acute diabetic pig model and the effects of local hyperglycemia.
    Velander P; Theopold C; Hirsch T; Bleiziffer O; Zuhaili B; Fossum M; Hoeller D; Gheerardyn R; Chen M; Visovatti S; Svensson H; Yao F; Eriksson E
    Wound Repair Regen; 2008; 16(2):288-93. PubMed ID: 18318812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Apligraf in acute wounds.
    Kirsner RS
    J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats.
    Wang W; Lin S; Xiao Y; Huang Y; Tan Y; Cai L; Li X
    Life Sci; 2008 Jan; 82(3-4):190-204. PubMed ID: 18164317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model.
    Pietramaggiori G; Scherer SS; Mathews JC; Alperovich M; Yang HJ; Neuwalder J; Czeczuga JM; Chan RK; Wagner CT; Orgill DP
    Wound Repair Regen; 2008; 16(2):218-25. PubMed ID: 18318807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute.
    Park SN; Kim JK; Suh H
    Biomaterials; 2004 Aug; 25(17):3689-98. PubMed ID: 15020144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing.
    Badillo AT; Chung S; Zhang L; Zoltick P; Liechty KW
    J Surg Res; 2007 Nov; 143(1):35-42. PubMed ID: 17950070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
    Karr JC
    Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced biological therapies for diabetic foot ulcers.
    Kirsner RS; Warriner R; Michela M; Stasik L; Freeman K
    Arch Dermatol; 2010 Aug; 146(8):857-62. PubMed ID: 20713816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasmid encoding HSP47 enhances collagen expression and promotes skin wound healing in an alloxan-induced diabetic model.
    Wang Z; Li L
    Cell Biol Int; 2009 Jul; 33(7):705-10. PubMed ID: 19268552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
    Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
    Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue engineering.
    Sefton MV; Woodhouse KA
    J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-18-23. PubMed ID: 10082603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.